Literature DB >> 11127719

Substance use disorders among homeless people in inner Sydney.

M Teesson1, T Hodder, N Buhrich.   

Abstract

BACKGROUND: The study aimed to assess the prevalence of alcohol and drug use disorders among homeless people in inner Sydney, to compare the Australian findings with the international literature and to examine treatment seeking.
METHOD: Two hundred and ten homeless men and women randomly selected from the dining rooms of inner Sydney refuges were interviewed. DSM-IV diagnoses over the past 12 months were based on the Composite International Diagnostic Interview (CIDI).
RESULTS: Half the homeless men and 15% of the women had a diagnosis of alcohol use disorder in the past 12 months. One in five had an opiate use disorder, one in five a cannabis use disorder and one in ten a sedative or stimulant use disorder.
CONCLUSIONS: Drug use disorders were more prevalent in this Australian sample than in comparable international studies.

Entities:  

Mesh:

Year:  2000        PMID: 11127719     DOI: 10.1007/s001270050263

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  3 in total

1.  Housing instability among people who inject drugs: results from the Australian needle and syringe program survey.

Authors:  Libby Topp; Jenny Iversen; Eileen Baldry; Lisa Maher
Journal:  J Urban Health       Date:  2013-08       Impact factor: 3.671

2.  A place to call home: study protocol for a longitudinal, mixed methods evaluation of two housing first adaptations in Sydney, Australia.

Authors:  Elizabeth Whittaker; Wendy Swift; Paul Flatau; Timothy Dobbins; Olivia Schollar-Root; Lucinda Burns
Journal:  BMC Public Health       Date:  2015-04-09       Impact factor: 3.295

Review 3.  The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis.

Authors:  Seena Fazel; Vivek Khosla; Helen Doll; John Geddes
Journal:  PLoS Med       Date:  2008-12-02       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.